<table width="60%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Effects on steady-state fexofenadine pharmacokinetics
after 7 days of co-administration with fexofenadine hydrochloride
120 mg every 12 hours in healthy adult subjects (n=24)</caption>
<col align="left" valign="top" width="33%"></col>
<col align="center" valign="top" width="34%"></col>
<col align="center" valign="top" width="34%"></col>
<thead>
<tr>
<th>
<content stylecode="italics">Concomitant Drug</content>
</th>
<th>
<content stylecode="italics">C<sub>maxSS</sub>
</content>
<br/>
<content stylecode="italics">(Peak plasma concentration)</content>
</th>
<th>
<content stylecode="italics">AUC<sub>ss(0–12h)</sub>
</content>
<br/>
<content stylecode="italics">(Extent of systemic exposure)</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Erythromycin<br/>(500 mg every 8 hrs)</td>
<td>+82%</td>
<td>+109%</td>
</tr>
<tr>
<td align="center" colspan="3">  </td>
</tr>
<tr>
<td>Ketoconazole<br/>(400 mg once daily)</td>
<td>+135%</td>
<td>+164%</td>
</tr>
</tbody>
</table>